Huawei Terminal's Wrist Dynamic Blood Pressure Recorder Gets National Medical Device License
TapTechNews August 16th news, the official website of the National Medical Products Administration shows that on August 5th, the "Wrist Dynamic Blood Pressure Recorder" of Huawei Terminal Co., Ltd. obtained the national medical device license, with models LCA-B10, LCA-B11, and LCA-B12, and the entrusted production enterprise shows "Huawei Machines Co., Ltd.".
The medical device registration license shows that this equipment consists of the main unit, cuff (wristband), and wireless charging base, and the cuff (wristband) contains an air bag; the equipment can be used to measure the systolic blood pressure, diastolic blood pressure, and pulse rate of the human body in a static situation in a single or different time periods set within 24 hours (only applicable to people aged 18 and above) for reference and analysis by medical staff.
Blogger @Uncle Looking at the Mountain said that this device is the Huawei WatchD2, that is, the next generation of Huawei WATCHD in 2021.
According to TapTechNews' previous report, the Huawei WATCHD wrist electrocardiogram and blood pressure recorder was released on December 23, 2021, supporting blood pressure measurement and electrocardiogram collection, and passed the second-class medical device registration of the Drug Administration, with an initial price of $418. (1 RMB≈0.143 US dollars).
